ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,226,512 | +23.1% | 118,884 | +39.4% | 0.01% | 0.0% |
| Q2 2023 | $2,620,769 | -37.4% | 85,256 | -26.6% | 0.01% | -28.6% |
| Q1 2023 | $4,187,731 | -20.5% | 116,229 | -12.8% | 0.01% | -30.0% |
| Q4 2022 | $5,268,846 | +6.0% | 133,321 | +7.8% | 0.01% | 0.0% |
| Q3 2022 | $4,969,000 | +105.9% | 123,673 | +115.5% | 0.01% | +400.0% |
| Q2 2022 | $2,413,000 | +164.9% | 57,382 | +145.2% | 0.00% | +100.0% |
| Q1 2022 | $911,000 | -18.1% | 23,405 | -16.2% | 0.00% | 0.0% |
| Q4 2021 | $1,113,000 | +82.5% | 27,917 | +65.3% | 0.00% | – |
| Q3 2021 | $610,000 | +45.6% | 16,885 | +65.2% | 0.00% | – |
| Q2 2021 | $419,000 | +94.0% | 10,223 | +106.0% | 0.00% | – |
| Q1 2021 | $216,000 | -12.9% | 4,963 | 0.0% | 0.00% | – |
| Q4 2020 | $248,000 | – | 4,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |